临床儿科杂志 ›› 2016, Vol. 34 ›› Issue (9): 670-.doi: 10.3969/j.issn.1000-3606.2016.09.008

• 综合报道 • 上一篇    下一篇

138 例儿童弥漫性肺泡出血临床特点及病因分析

王维, 张慧, 田小银, 张光莉, 陈明, 孟庆清, 罗征秀   

  1. 重庆医科大学附属儿童医院呼吸科  儿童发育疾病研究教育部重点实验室 儿童发育 重大疾病国家国际科技合作基地  儿科学重庆市重点实验室( 重庆 400014)
  • 收稿日期:2016-09-15 出版日期:2016-09-15 发布日期:2016-09-15
  • 通讯作者: 罗征秀 E-mail:luozhengxiu816@163.com
  • 基金资助:
    国家临床重点专科建设项目(No.2011-873)

The clinical characteristics and etiological analysis of diffuse alveolar hemorrhage in 138 children

 WANG Wei, ZHANG Hui, TIAN Xiaoyin, ZHANG Guangli, CHEN Ming, MENG Qingqing, LUO Zhengxiu    

  1. Department of Respiration, Children’s Hospital Affiliated to Chongqing University, Chongqing 400014, China
  • Received:2016-09-15 Online:2016-09-15 Published:2016-09-15

摘要: 目的 分析儿童弥漫性肺泡出血(DAH)的临床特点及其常见病因。方法 回顾性分析138例首次诊断DAH 患儿的临床资料,总结病因、诊治经过及预后。结果 138例患儿中男76例、女62例;临床表现为面色苍白130例(94.2%), 咳嗽86例(62.3%),发热74例(53.6%),气促67例(48.6%),咯血59例(42.8%),呼吸困难43例(31.2%);胸部影像 学改变以斑片影及磨玻璃样影为主;痰液、胃液及支气管肺泡灌洗液含铁血黄素巨噬细胞检出率90.8% (79/87)。 引起 DAH常见基础疾病分别为特发性肺含铁血黄素沉着症65例,血液系统疾病22例,血管炎性疾病15例,感染性疾病14例, 心血管疾病5例。DHA患儿急性期病死率23.2% (32/138)。 结论 DAH是危及生命的临床急重症,病因复杂多样,急性 期病死率高,糖皮质激素是多数患者的首选治疗方法。

Abstract: Objective To analyze the clinical feature and common etiology of diffuse alveolar hemorrhage (DAH) in children. Methods Clinical data from 138 children with initially diagnosed DAH were retrospectively analyzed. The etiology, diagnosis, treatment, and prognosis had been summarized. Results Among 138 children, 76 were male and 62 were female. The clinical features are pallor (130 cases, 94.2%), cough (86 cases, 62.3%), fever (74 cases, 53.6%), anhelation (67 cases, 48.6%), hemoptysis (59 cases, 42.8%) and dyspnea (43 cases, 31.2%). Chest imaging changes were mainly patch shadow and ground glass shadow. Moreover, the detection rate of hemosiderin cells in sputum, gastric juice and bronchoalveolar lavage fluid was 90.8% (79/87). The common underlying diseases that caused DAH were idiopathic pulmonary hemosiderosis (65 cases), hematological system disease (22 cases), vascular inflammatory diseases (15 cases), infectious diseases (14 cases) and cardiovascular disease (5 cases). The mortality rate in acute phase of DHA was 23.2% (32/138). Conclusions DHA is a life-threatening clinical emergency disease, its cause was complex and diverse, and the acute mortality rate is high. Glucocorticoid is the first choice of treatment for majority of patients.